- PR Newswire•3 days ago
NEW YORK, Jan. 13, 2017 /PRNewswire/ -- WebMD Health Corp. (WBMD) today announced that its Board of Directors has appointed Ian G. Banwell to WebMD's Board. Mr. Banwell was appointed to fill a vacancy created when Jerome C. Keller resigned from the Board on January 11, 2017. Mr. Banwell was Chief Investment Officer of Bank of America from 2000 to 2007. He left Bank of America in 2007 to start Round Table Investment Management and was its CEO until 2015. He is currently Managing Partner of Aberdeen Enterprises, LLC, a company focused on producing and investing in a variety of intellectual property and content. Mr. Banwell also served as a member of the U.S. Treasury's Borrowing Advisory Committee from 2001 to 2012 and as its Chairman in 2005 and 2006. Mr. Banwell is joining WebMD's Board as an additional Class II director.
- Zacks•25 days ago
WebMD Health Corp. (WBMD) announced that it has completed a tender offer to purchase 2 million shares of its common stock.
- PR Newswire•26 days ago
WebMD has accepted for purchase 2,000,000 shares of its Common Stock, including all "odd lots" validly tendered, at a purchase price of $55.00 per share, for an aggregate purchase price of $110 million. Based on the final tabulation by American Stock Transfer & Trust Company, the Depositary for the tender offer, approximately 14.9 million shares of WebMD Common Stock were properly tendered and neither withdrawn nor tendered conditionally by stockholders with conditions that were not met. WebMD has been informed by the Depositary that, after giving effect to the priority for an aggregate amount of approximately 915,000 "odd lot" shares, the final proration factor for the remaining tendered shares is approximately 7.74%.
WBMD : Summary for WebMD Health Corp - Yahoo Finance
WebMD Health Corp. (WBMD)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||50.94 x 200|
|Ask||51.06 x 100|
|Day's Range||49.92 - 51.13|
|52 Week Range||45.46 - 67.55|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||28.49|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|